Nowak, Ł.; Krajewski, W.; Dejnaka, E.; Małkiewicz, B.; Szydełko, T.; Pawlak, A.
Ubiquitin-Specific Proteases as Potential Therapeutic Targets in Bladder Cancer—In Vitro Evaluation of Degrasyn and PR-619 Activity Using Human and Canine Models. Biomedicines 2023, 11, 759.
https://doi.org/10.3390/biomedicines11030759
AMA Style
Nowak Ł, Krajewski W, Dejnaka E, Małkiewicz B, Szydełko T, Pawlak A.
Ubiquitin-Specific Proteases as Potential Therapeutic Targets in Bladder Cancer—In Vitro Evaluation of Degrasyn and PR-619 Activity Using Human and Canine Models. Biomedicines. 2023; 11(3):759.
https://doi.org/10.3390/biomedicines11030759
Chicago/Turabian Style
Nowak, Łukasz, Wojciech Krajewski, Ewa Dejnaka, Bartosz Małkiewicz, Tomasz Szydełko, and Aleksandra Pawlak.
2023. "Ubiquitin-Specific Proteases as Potential Therapeutic Targets in Bladder Cancer—In Vitro Evaluation of Degrasyn and PR-619 Activity Using Human and Canine Models" Biomedicines 11, no. 3: 759.
https://doi.org/10.3390/biomedicines11030759
APA Style
Nowak, Ł., Krajewski, W., Dejnaka, E., Małkiewicz, B., Szydełko, T., & Pawlak, A.
(2023). Ubiquitin-Specific Proteases as Potential Therapeutic Targets in Bladder Cancer—In Vitro Evaluation of Degrasyn and PR-619 Activity Using Human and Canine Models. Biomedicines, 11(3), 759.
https://doi.org/10.3390/biomedicines11030759